A Study Comparing Two Standard of Care Adjuvant Chemotherapy Regimens for Lower Risk HER-2 Positive Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: TC-H x Paclitaxel (P) + Trastuzumab(T)
Sponsor: Lawson Health Research Institute
Collaborators: The Ottawa Hospital